Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The measles virus is a highly contagious, single-stranded, negative-sense RNA virus and the causative agent of measles, an acute viral respiratory illness. It belongs to the genus *Morbillivirus* within the family Paramyxoviridae. Humans are the only natural hosts and transmission occurs primarily through airborne respiratory droplets. The virus utilizes CD150/SLAM and Nectin-4 as cellular entry receptors, leading to systemic infection and a characteristic rash. Measles infection causes transient immunosuppression making patients susceptible to secondary infections.
Vaccines stimulate the body's immune system to produce antibodies against the measles virus, preventing infection or reducing the severity of the disease. Ribavirin inhibits viral RNA synthesis. Vitamin A supplementation aims to reduce morbidity and mortality from measles
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Measles Virus (MV).